Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan
SEATTLE, WA / ACCESS Newswire / May 22, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ('Aptevo' or the 'Company'), today announced that it will conduct a reverse stock split of its outstanding shares of common stock, par value $0.001 per share ('Common Stock'), at a ratio of 1-for-20 (the 'Reverse Stock Split'). The Reverse Stock Split is expected to become effective on May 23, 2025, at 5:01 p.m. Eastern Time (the 'Effective Time'), with shares expected to begin trading on the Nasdaq Capital Market, on a split-adjusted basis, at market open on May 27, 2025. In connection with the Reverse Stock Split, every 20 shares of Common Stock issued and outstanding as of the Effective Time will be automatically converted into one share of Common Stock. No change will be made to the trading symbol for the Common Stock, 'APVO,' in connection with the Reverse Stock Split.
The Reverse Stock Split is part of the Company's plan to maintain compliance with the continued listing standards of The Nasdaq Capital Market, among other benefits.
The Reverse Stock Split was approved by the Company's stockholders at the Company's Special Meeting of Stockholders held on May 14, 2025 (the 'Special Meeting') to be effected in the Board's discretion within approved parameters. Following the Special Meeting, the final ratio was approved by the Company's Board on May 21, 2025.
The Reverse Stock Split will reduce the number of shares of outstanding Common Stock from approximately 13.5 million shares (as of the date of this press release) to approximately 0.7 million shares, subject to adjustment for rounding, as discussed below and potential additional issuances through the effective date of the Reverse Stock Split.
The Reverse Stock Split will affect all issued and outstanding shares of Common Stock. All outstanding options, restricted stock units, warrants, and other securities entitling their holders to purchase or otherwise receive shares of Common Stock will be adjusted as a result of the reverse split, as required by the terms of each security. The number of shares available to be awarded under the Company's equity incentive plans will also be appropriately adjusted. Following the reverse split, the par value of the Common Stock will remain unchanged at $0.001 par value per share. The Reverse Stock Split will not change the authorized number of shares of Common Stock or preferred stock. No fractional shares will be issued in connection with the Reverse Stock Split, and stockholders who would otherwise be entitled to receive a fractional share of Common Stock will be entitled to receive a cash payment (without interest).
Additional information regarding the Reverse Stock Split is available in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission ('SEC') on April 25, 2025, and a Current Report on Form 8-K which the Company plans to file following the Effective Time.
About Aptevo Therapeutics
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer. The company has two clinical candidates. Mipletamig is currently being evaluated in RAINIER, a Phase 1b/2 trial for the treatment of frontline acute myeloid leukemia in combination with standard-of-care venetoclax + azacitidine. Mipletamig has received orphan drug designation ('orphan status') for AML according to the Orphan Drug Act. ALG.APV-527, a bispecific conditional 4-1BB agonist, only active upon simultaneous binding to 4-1BB and 5T4, is being co-developed with Alligator Bioscience and is being evaluated in a Phase 1 clinical trial for the treatment of multiple solid tumor types likely to express 5T4. The Company has three pre-clinical candidates with different mechanisms of action designed to target a range of solid tumors. All pipeline candidates were created from two proprietary platforms, ADAPTIR® and ADAPTIR-FLEX® The Aptevo mission is to improve treatment outcomes and transform the lives of cancer patients. For more information, please visit www.aptevotherapeutics.com.
Forward-Looking Statements
This press release includes 'forward-looking statements', including information about management's view of the Company's future expectations, plans and prospects, within the safe harbor provisions provided under federal securities laws, including under The Private Securities Litigation Reform Act of 1995. Words such as 'expect,' 'estimate,' 'project,' 'budget,' 'forecast,' 'anticipate,' 'intend,' 'plan,' 'may,' 'will,' 'could,' 'should,' 'believes,' 'predicts,' 'potential,' 'continue' and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results and, consequently, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements and factors that may cause such differences include, without limitation, our ability to continue as a going concern; a deterioration in Aptevo's business or prospects; further assessment of preliminary or interim data or different results from later clinical trials; adverse events and unanticipated problems and adverse developments in clinical development, including unexpected safety issues observed during a clinical trial; and changes in regulatory, social, macroeconomic and political conditions. These risks are not exhaustive, the Company faces known and unknown risks. Additional risks and factors that may affect results of the Company are set forth in the Company's filings with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and its subsequent reports on Form 10-Q and current reports on Form 8-K. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from the Company's expectations in any forward-looking statement. Readers are cautioned not to place undue reliance upon any forward-looking statements, including but not limited to statements about the effectuation of the Reverse Stock Split. These reports and filings are available at www.sec.gov and are available for download, free of charge, soon after such reports are filed with or furnished to the SEC, on the 'Investors' page of the Company's website at www.apvotherapeutics.com. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, the Company does not assume any obligation to update any forward-looking statement to reflect new information, events, or circumstances.
Contact:
Miriam Weber Miller
Head, Investor Relations & Corporate Communications
Aptevo Therapeutics
Email: [email protected] or [email protected]
Phone: 206-859-6628
SOURCE: Aptevo Therapeutics
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Meet the Only S&P 500 Stock That Yields Over 10%. Here's Why It Could Be Worth Buying in June.
Dow Inc. is under pressure due to weak customer demand, global competition, and high costs. Management doesn't want to cut the dividend, but it could be a good choice given cost pressures. Even if Dow cut its dividend in half, it would still have an excellent yield. 10 stocks we like better than Dow › Commodity chemical giant Dow Inc. (NYSE: DOW) is hovering around a five-year low and is now down around 50% from its spin-off price when DowDuPont split into three separate companies in April 2019. Dow has kept its dividend the same for the last six years. But since the stock has been beaten down so much, Dow's yield has jumped to a whopping 10.3% at the time of this writing -- making it the highest-yielding component in the S&P 500 (SNPINDEX: ^GSPC). Here's why Dow's challenges persist and why the dividend stock could be worth buying now, even if the company reduces its payout. Dow makes commodity chemicals -- mainly plastics and synthetic rubber. Dow has hundreds of products that are used either directly or indirectly across virtually every industry in the economy -- from electronics to food and beverage packing, textiles, construction, industrial applications, healthcare, cosmetics, household products like detergents and dish soaps, and more. Since these products are commodities, they lack pricing power. This is similar to the dynamic in oil and gas, where a gallon of unleaded gasoline sold at ExxonMobil is virtually the same as a gallon sold at Chevron. Consumers will largely make a purchase decision based on price, not brand. So Dow must achieve scale and operating leverage to ensure it can produce products at a competitive cost relative to its peers. Economic growth typically coincides with higher commodity chemical demand. But lately, two factors have been working against Dow. Demand is low across several end markets due to higher borrowing costs from elevated interest rates and slowing economic growth in key markets -- namely Europe. Another major challenge is competition. China has been ramping up investments in manufactured goods -- from chemicals to solar panels -- to take market share on the global stage. If China can produce chemicals sold by Dow for a cheaper price, it can undercut Dow on pricing. Dow is also working to become a more sustainable company by investing in plastic waste recycling and the world's first net-zero emissions integrated ethylene cracker -- known as its Path2Zero project in Alberta, Canada. However, on its first-quarter 2025 earnings call, Dow said that it is pausing Path2Zero to reduce its spending. Dow estimates that the pause will save the company $1 billion and reduce enterprise spending to $2.5 billion from $3.5 billion. Dow's latest quarter showed some signs of improvement, as it was the sixth consecutive quarter of year-over-year volume growth. But net sales still fell 3% due to a lack of pricing power -- which illustrates that demand is improving but competition is challenging. Dow's operating margin has gone from pre-pandemic levels around 8%, to 2022 highs in the mid-teens, to just 3.3% currently. As you can see in the chart, Dow's stock price is under pressure due to declining revenue and margins. The company's profit margin, which accounts for interest and taxes, is less than 1%. Dow is converting just $0.69 for every $100 in sales into profit -- which is unsustainable. It's also worth mentioning that Dow is free-cash-flow (FCF) negative, meaning that its operations can't support its dividend expense, so it has to rely on other means, such as debt. Since Dow isn't producing enough cash or earnings to cover its dividend, it can either sell assets, pull back on spending, take on more debt, cut the payout, or a blend of multiple ideas. As mentioned, Dow did pause its Path2Zero project, which could reduce its long-term earnings growth but will save on near-term expenses. On May 1, Dow completed the sale of a 40% equity stake in Diamond Infrastructure Solutions, which has infrastructure assets along the U.S. Gulf Coast. The sale netted Dow with $2.4 billion in initial cash proceeds, with the potential for $600 million more in proceeds if an option is exercised. Dow spent $494 million on dividends in its recent quarter, so the sale alone can cover the dividend expense for roughly five quarters. But selling assets or taking on debt to cover dividends is like plugging holes in a sinking ship. A preferred approach is to get the ship afloat -- or back to higher margins and consistent FCF -- so that operations can cover the dividend, and ideally, still have cash left over to pay down debt or buy back stock. In addition to savings from Path2Zero and the asset sale, Dow is also receiving around $1 billion in proceeds from a court settlement, and $1 billion in targeted cost savings by 2026, including $300 million in 2025. All told, Dow is on track to receive around $6 billion in additional cash or cost savings, most of which is coming this year. It's also worth mentioning that Dow has just $500 million in debt maturing in 2025 and no substantial debt maturities until 2027. So for now, its debt seems manageable. However, if Dow's margins remain depressed, it will have few choices but to cut the dividend. Dow's 10.3% yield is so high that the company could cut the payout by two-thirds and Dow would still yield 3.4% -- which is a solid source of passive income. When asked about the dividend on Dow's first-quarter earnings call, management responded that the cash and cost savings will help support the dividend, but that the situation is evolving and Dow will have to continue monitoring tariffs and macro factors. Dow may be a worthwhile turnaround play for investors who aren't banking on its dividend yield staying above 10%. If the company can use its cash proceeds wisely and continue managing its expenses, it could help weather the storm until economic conditions improve. However, it remains to be seen how Dow will hold up against the competition, even during a more normal operating environment. Dow has a long-term goal to have its dividend make up 45% of operating income. If Dow can get its operating margin back around the 8% to 9% range or if it cuts its dividend in half, it should be around that goal -- assuming it doesn't lose more pricing power. And if Dow can gradually improve its margins, the stock will begin to look dirt cheap. In sum, Dow has the cash and lack of debt obligations to afford its dividend in 2025. Going forward, I expect the company to cut its dividend at least in half or maybe by two-thirds if conditions don't improve, or it may decide to sustain the payout if there's a significant recovery in macro conditions. Risk-tolerant investors may want to scoop up shares of Dow now, with the stock at multiyear lows. In contrast, other investors may want to take a wait-and-see approach to Dow, as the next year will be pivotal in determining whether the company overcomes its present challenges or goes through with a dividend cut. Before you buy stock in Dow, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Dow wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor's total average return is 997% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chevron. The Motley Fool has a disclosure policy. Meet the Only S&P 500 Stock That Yields Over 10%. Here's Why It Could Be Worth Buying in June. was originally published by The Motley Fool
Yahoo
9 minutes ago
- Yahoo
Elon Musk threatens to decommission SpaceX's Dragon spacecraft after Trump feud. What does it mean for the US space industry?
When you buy through links on our articles, Future and its syndication partners may earn a commission. An explosive, and very public, feud between President Donald Trump and SpaceX founder Elon Musk on Thursday (June 5) has raised doubts over the future of America's space industry. The war of words could place $22 billion of SpaceX's government contracts with multiple U.S. space programs at risk, according to one estimate, although the real figure — which remains classified — could be significantly higher. Following threats from the president on his social media platform Truth Social that the U.S. could cancel the government contracts and subsidies awarded to Musk's companies, the CEO of SpaceX retorted that his space company would "begin decommissioning its Dragon spacecraft immediately." Hours later, Musk responded to a follower telling him to "cool off" by saying "Good advice. Ok, we won't decommission Dragon." The disagreement began on Tuesday (June 3) when Musk criticized the administration's proposed tax and spending bill on his social media platform X. "This massive, outrageous, pork-filled Congressional spending bill is a disgusting abomination. Shame on those who voted for it: you know you did wrong. You know it," Musk wrote on X. Related: 'No radio astronomy from the ground would be possible anymore': Satellite mega-swarms are blinding us to the cosmos — and a critical 'inflection point' is approaching This then escalated into a full-blown social media feud on Thursday, with Musk claiming that Trump's name appears in unreleased files relating to sex offender Jeffrey Epstein. The White House condemned these allegations. "This is an unfortunate episode from Elon, who is unhappy with the One Big Beautiful Bill because it does not include the policies he wanted," representatives wrote on X. Trump then claimed Musk "just went CRAZY," posting: "The easiest way to save money in our Budget, Billions and Billions of Dollars, is to terminate Elon's Governmental Subsidies and Contracts. I was always surprised that Biden didn't do it!" SpaceX's Dragon capsule is a reusable spacecraft capable of carrying up to seven passengers and cargo to and from Earth orbit, according to SpaceX. NASA currently relies on the capsule to ferry astronauts to the International Space Station (ISS), so canceling these government contracts effectively eliminates America's ability to launch astronauts to space from American soil, Live Science's sister website, reported. NASA also heavily relies on SpaceX for other space programs, having selected the Starship Human Landing System (HLS), a lunar lander variant of the company's next-generation Starship spacecraft, to carry American astronauts to the moon for the first time in more than 50 years aboard the 2027 Artemis 3 mission. NASA is investing $4 billion into Starship's development, and canceling its contract could seriously handicap NASA and the future of U.S.-led space exploration. While other competitors exist, such as Amazon founder Jeff Bezos's Blue Origin and Boeing's Starliner spacecraft, they lag far behind SpaceX. RELATED STORIES —Facing steep funding cuts, scientists propose using black holes as particle colliders instead of building new ones on Earth —Trump's 2026 budget would slash NASA funding by 24% and its workforce by nearly one third —NASA plans to build a giant radio telescope on the 'dark side' of the moon. Here's why. The Starliner capsule is not yet certified to fly operational astronaut missions and was responsible for "stranding" two astronauts on the ISS for nine months last year. The astronauts returned to Earth on March 18 aboard a SpaceX Dragon capsule, and neither Boeing nor NASA have offered any significant updates into fixes that will make Starliner flightworthy. SpaceX's lead on its competitors is reflected in the size of its government subsidies. In April, the U.S. Space Force, the military branch of U.S. space exploration, awarded the company nearly $6 billion in launch contracts, while the United Launch Alliance received $5.4 billion and Blue Origin $2.4 billion. In response to the feud between Musk and Trump, NASA press secretary Bethany Stevens declined to comment on SpaceX, but she did tell Reuters that "we will continue to work with our industry partners to ensure the president's objectives in space are met." NASA's deputy administrator Lori Garver told Reuters that, as well as not being in national interests, canceling SpaceX's contacts would probably not be legal. However, she also added that "a rogue CEO threatening to decommission spacecraft, putting astronauts' lives at risk, is untenable."
Yahoo
9 minutes ago
- Yahoo
Ohio food banks strain as Trump slashes federal aid programs
By P.J. Huffstutter COLUMBUS, Ohio (Reuters) -On a warm spring morning, volunteers at the Mid-Ohio Food Collective plucked cucumbers from a greenhouse where a state psychiatric hospital once stood and the land lay fallow. Now the state's largest food bank is working that ground again, part of an urgent effort to shore up supplies amid shrinking federal support, including deep funding cuts under President Donald Trump. They are planting more. Prepping soil for fruit trees, and installing hives for honey. In the greenhouse, crates of romaine and butterhead lettuce were packed for delivery, bound for a pantry across town. Back at headquarters in Grove City, staff chased leads from grocers, manufacturers, even truckers looking to unload abandoned freight. Every pallet helped. Every pound counted. In a state that handed Trump three straight wins, where Trump flags flap near food aid flyers pinned on bulletin boards, the cost of his austerity push is starting to show. "Food banks will still have food," said Mid-Ohio CEO Matt Habash. "But with these cuts, you'll start to see a heck of a lot less food, or pantries and agencies closing. You're going to have a lot of hungry, and a lot less healthy, America." For decades, food banks like Mid-Ohio have been the backbone of the nation's anti-hunger system, channelling government support and donations from corporations and private donors into meals and logistics to support pantries at churches, non-profits and other organizations. If a food bank is a warehouse, food pantries are the store. Outside one of those – the Eastside Community Ministry pantry in rural Muskingum County, Ohio – Mary Dotson walked slow, cane in hand. The minute she stepped through the doors, her whole body seemed to lift. They call her Mama Mary here, as she's got the kind of voice that settles you down and straightens you out in the same breath. The regulars grin as Dotson, 77, pats shoulders, swaps recipes. She had tried to do everything right: built a career, raised five children, planned for the quiet years with her husband. But after he died and the kids moved away, the life they'd built slipped out of reach. Now her monthly Social Security check is $1,428. She budgets $70 of that for groceries, and she gets $23 in food benefits as well. She started as a volunteer at Eastside. Simple math convinced her to become a customer. 'I figured if I'm going to take these things,' Dotson said, 'I'm going to work here, too.' CAMPAIGN FODDER The Mid-Ohio Food Collective was born out of church basements and borrowed trucks nearly a half-century ago, when factory closures left more families hungry. It's now the state's largest food bank, feeding more than 35,000 Ohio families a week. It supplies more than 600 food pantries, soup kitchens, children and senior feeding sites, after-school programs and other partner agencies. When Trump returned to office in January, Mid-Ohio was already slammed. Pantry visits across its 20 counties hit 1.8 million last year, nearly double pre-COVID levels, and are continuing to grow this year. The biggest surge came from working people whose paychecks no longer stretch far enough due to pandemic-era inflation under Joe Biden's presidency, staff said. Then came the Trump cuts. In March, the U.S. Department of Agriculture (USDA) cancelled the pandemic-era Local Food Purchase Assistance (LFPA) program, which funded about $500 million annually for food banks; and froze about $500 million in funding for The Emergency Food Assistance Program (TEFAP), one of the agency's core nutrition programs that supplies food to states to pass on to food banks for free. Much of the food Mid-Ohio distributes is donated, but donations alone can't stock a pantry consistently. Its current $11.1 million purchasing budget, built from federal, state and private dollars, helps fill the gaps. The March cuts wiped out about 22% of Mid-Ohio's buying power for next fiscal year – funds and food that staff are trying to replace. In early December, Mid-Ohio ordered 24 truckloads filled with milk, meat and eggs for delivery this spring and summer. The food came through the TEFAP program, using about $1.5 million in government funding. The first delivery was scheduled to show up April 9. The only thing to arrive was a cancellation notice. USDA said in a statement Secretary Brooke Rollins is working to ensure federal nutrition spending is efficient, effective and aligned with the administration's budget priorities. More cuts could come. Last month, the Republican-controlled U.S. House of Representatives passed Trump's tax and spending bill. It called for $300 billion in cuts to food benefits for low income people under the Supplemental Nutrition Assistance Program (SNAP), which fed nearly 1.4 million Ohioans in January, according to the latest state data. If the cuts survive the Senate and are passed into law, it annually would cost Ohio at least $475 million in state funding to maintain current SNAP benefits, plus at least $70 million for administrative program costs, said Cleveland-based The Center for Community Solutions, an independent, nonpartisan policy research group. That would consume nearly every state-controlled dollar in Ohio's Department of Job and Family Services budget, roughly 95% of the general revenue meant to help fund everything from jobless claims to foster care. Ohio Gov. Mike DeWine and other lawmakers in this GOP supermajority state capitol, facing a constitutional requirement to pass a balanced budget, told Reuters that extra money for food banks isn't there. The proposed fiscal 2025 Ohio budget would set food bank funding back to 2019 levels – or about 23% less than what it spent this year, in a state where nearly one in three people qualify for help. Federal safety-net programs have become campaign fodder, too. At a recent Ohio Republican Party fundraiser in Richland County, Ohio, voters in suits and Bikers for Trump gear alike listened to Vivek Ramaswamy, the tech millionaire turned presidential candidate now running for Ohio governor. He spoke out against "a culture of dependence on the entitlement state that has festered in our country for 60 years." SAVING A PENNY So what happens when the government pulls back and supplies thin? If you're Victoria Brown and her small team of four, it means working the phones, chasing leads, watching markets, and moving fast. At Mid-Ohio's offices in Grove City, the food bank's director of sourcing sipped her coffee and squinted at her screen, eyes tracking the price-per-pound of cucumbers down to the cent. Saving a penny might seem inconsequential, unless you're trying to buy 40,000 pounds. In a supply chain that has relied on steady government support, food donations have become even more important, even as they grow more haphazard in both timing and what's available. Outside Brown's office, one staffer was trying to track down a shipment of pineapples. The rest were on the road, talking crop conditions with farmers, negotiating delivery times with suppliers and checking with grocers to see what might be sitting in the back, waiting for a second life. Brown glanced at her inbox, where new offers stacked up: At 11:10 a.m., one pallet of frozen chicken. I'll find out why it's being donated, a staffer promised. At 11:13 a.m., four pallets of cereal, bulk packed in industrial totes. Brown jotted a note for the volunteer coordinator: Anyone available to scoop a thousand pounds of cereal into small bags? RACING THE CLOCK Some of that food may be headed for Mid-Ohio's Norton Market, a modern food pantry built to feel like a real store in Columbus. The man in charge here is Denver Burkhart. He moves with the kind of precision the military teaches and life reinforces. At 35, he looks every bit the soldier he still is – broad-shouldered and lean, squared off at the edges. Fifteen years in the Army, two tours in Afghanistan, one in Iraq, now he has a mission back home until he serves overseas again with the Ohio Army National Guard. He started the morning as he always does: at a laptop in the back cramped office, racing to secure whatever free or discounted goods Brown's team had found. He leaned over the keyboard, one eye on the clock, the other on the blinking screen. The inventory system had just refreshed. The race was on to fill his mental list. His fingers clicked fast, steady, practiced. He hovered over baby formula. More moms have been showing up lately. Forty cases into the cart. Maybe too many – but if he waited, they'd be gone. "I rely heavily on the free product," he said. "Without it, we'd be hurting really bad." "WATER DAYS" Across town, Shannon Follins checks on her ice supply. It's for what she calls the "water days." Follins, 37, is raising three kids, including 3-year-old twins. One is autistic; he hasn't found his words yet. Until recently, Follins worked third shift at Waffle House for $5.25 an hour, and now she's studying for a degree in social services. Family brings groceries when they can. But it's the pantry at Broad Street Presbyterian Church, stocked by Mid-Ohio, that lets her make meals that feel like more than survival. One recent night, her daughter Essence twirled barefoot across their kitchen floor, dancing to the sounds of boiling pasta and chicken simmering in the pan. When there was nothing else to eat, she filled her kids' bellies with tap water and a mother's promise that tomorrow might be better. "It gives me a sense of security," she said, nodding toward the plastic jugs stacked in her freezer. If the government cuts food aid? She's prepared for more water days.
